Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Caribou Biosciences’ President and CEO Rachel Haurwitz Named to Fortune’s 2016 “40 under 40” List of Most Influential Young People in Business

Caribou Biosciences,Inc.
Posted on: 26 Sep 16

Caribou Biosciences, Inc., a developer of CRISPR-Cas technologies for genome engineering, announced today that Rachel Haurwitz, Ph.D., President and Chief Executive Officer, has been selected for Fortune magazine’s 2016 “40 Under 40” list, the publication’s annual ranking of the most influential young people in business.

Dr. Haurwitz, No. 23 on this year’s list, is a co-founder of Caribou and has served as President and CEO since its inception. As part of Dr. Haurwitz’s profile, Fortune notes “She thought she was going to be a biotech patent IP lawyer, but Haurwitz’s love of science propelled her in another direction: partnering with famed biochemistry researcher Jennifer Doudna to cofound Caribou, one of the leading startups pursuing commercial applications of the genome-editing tool Crispr.”

Dr. Haurwitz is also a co-founder of Intellia Therapeutics, where she serves as a member of the board of directors. She is an inventor on several patents and patent applications covering multiple CRISPR-derived technologies, and she has co-authored scientific papers in high impact journals characterizing CRISPR-Cas systems. Rachel earned an A.B. in Biological Sciences from Harvard College, and received a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley.

The new issue of Fortune hits newsstands today.

About Caribou Biosciences
Caribou is a developer of cellular engineering and analysis solutions based on CRISPR technologies. The Company was founded by pioneers of CRISPR-Cas biology based on research carried out in the Doudna Laboratory at the University of California, Berkeley. Caribou's tools and technologies provide transformative capabilities to therapeutic development, agricultural biotechnology, industrial biotechnology, and basic and applied biological research. For more information, visit and follow the Company @CaribouBio. "Caribou Biosciences" and the Caribou logo are trademarks of Caribou Biosciences, Inc.

View source version on

Business Wire

Last updated on: 26/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.